Sinopharm Group (01099.HK): Sinopharm Group Co., Ltd. (600511.SH) achieved net profit attributable to shareholders of approximately RMB 1.476 billion in the first three quarters, a year-on-year decrease of 1.07%.

Zhitong Finance APP News, Sinopharm Group (01099.HK) announced that Sinopharm Shares (600511.SH) achieved revenue of approximately RMB 40.606 billion in the first three quarters of 2026, a year-on-year increase of 3.11%; net profit attributable to shareholders of the listed company was approximately RMB 1.476 billion, a year-on-year decrease of 1.07%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was approximately RMB 1.475 billion, a year-on-year increase of 0.36%; basic earnings per share were RMB 1.9566.